|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,362.00 GBX | +0.21% |
|
-0.38% | -1.01% |
| Jul. 09 | Major deals involving U.S. drugmakers and biotechs over the past decade | RE |
| Jul. 09 | Berenberg Lifts AstraZeneca Price Target, Earnings Forecasts on Drug Pipeline Strength | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AZN Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
